HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

PEGylated staphylokinase SY161

in phase II clinical trials (2002) for treating acute myocardial infarction
Also Known As:
staphylokinase SY161, PEG-modified
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results